BioBusiness - Comprehensive Advanced Program on BioEntrepreneurship at USI



This is a one-week comprehensive program aimed to promote entrepreneurship in

the field of Biotechnology. It provides an in-depth understanding of what it takes to

set up and finance successful biotechnology companies in Europe.

Extensive discussions and case studies will emphasize the challenging issues that are

critical to this relatively new market opportunity.

During the week, participants may draft a plan for developing a new idea in their


Participants will be given guidance on how to take on leadership roles in their communities,

to start and fund their own business, or play a more active role in investing

in life-sciences ventures.



The program is tailored to the needs of individuals planning to create, finance and

invest in or support successful biotechnology companies. Our target public includes:

• Scientists and engineers wishing to commercialize drugs and technologies

• Entrepreneurs and managers from pharmaceutical or biotech companies who

wish to explore and gain an insight into the global biotechnology sector

The number of participants is limited to 30.



The program is organized in modules with emphasis on Life Sciences, Entrepreneurship

and Venture Finance. A wide-ranging overview of the segments of the life sciences

industry will help orient entrepreneurs and investors.

Participants will be trained on how to start and finance a BioBusiness. The teaching

program also includes the mandatory regulatory and legal frameworks that are

instrumental in the BioBusiness.

Working in teams participants will be asked to design and develop a plan for developing

new business concepts. Teams will tackle an eminently interdisciplinary

project, requiring contributions from various disciplines and offering excellent opportunities

for knowledge and skills enhancement. Participants will prepare and

pitch an executive summary at the end of the program.

Lectures will be complemented by case studies and extensive discussions.

Participants will be able to interact and network with biotechnology entrepreneurs

and investors.

Lectures and seminars will be held by a world-class team of lecturers and instructors

from industry, academia, and venture capital.


CHF 4’000.-

Registration fees include tuition, hospitality (all lunches, coffee breaks and the evening


An early-bird rate of CHF 3’200.- applies until 15 April 2018.

If you are affiliated to an early-stage venture or an academic institution you will be eligible

for a discount on tuition fees.

Fees are payable in advance on receipt of confirmation of registration.





Contacts/For more information

Dr. Heidrun Flaadt Cervini, Director CASE BioMed

Università della Svizzera italiana

Via G. Buffi 13, 6904 Lugano

Tel.: +41 58 666 4268, Fax: +41 58 666 4619

e-mail: info [at]

For further information and registration: